Reuters logo
3 个月前
BRIEF-Cytokinetics announces orphan drug designation for CK-2127107 for treatment of spinal muscular atrophy
2017年5月15日 / 中午11点50分 / 3 个月前

BRIEF-Cytokinetics announces orphan drug designation for CK-2127107 for treatment of spinal muscular atrophy

May 15 (Reuters) - Cytokinetics Inc

* Cytokinetics announces orphan drug designation for CK-2127107 for the treatment of spinal muscular atrophy

* Expects to see results from its ongoing phase 2 clinical trial for ck-2127107 later this year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below